Growth hormone treatment

There may be a significant negative correlation between endogeneous testosterone and Lp(a) levels in man (DIO), while, on the other hand, growth hormone treatment increases Lp(a) levels (E6, 02). 

E6. Eden, S., Wiklund, O., Oscarsson, J., Rosen, T., and Bengtsson, B. A., Growth hormone treatment of growth hormone deficient adults results in a marked increase in lipoprotein(a) and HDL-cholesterol concentration. Atheroscler. Thromb. 13, 296-301 (1993). 

Olivecrona, H., Ericsson, S., Berglund, L., and Angelin, B., Increased concentration of serum lipoprotein(a) in response to growth hormone treatment. BMJ 306, 1726-1727 (1993). 

Hintz, R.L., The prismatic case of Creutzfeldt-Jakob disease associated with pituitary growth hormone treatment. J Clin Endocrinol Metab, 1995. 80(8) 2298-301. 

Fine, R.N., E.C. Kohaut, D. Brown, and A.J. Perlman, Growth after recombinant human growth hormone treatment in children with chronic renal failure report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group. J Pediatr, 1994.124(3) 374-82. 

GROWTH HORMONE TREATMENT OF PEDIATRIC PATIENTS WITH SHORT STATURE... 

Responses to hormonal manipulations and fasting. Activities responded in a parallel fashion to glucocorticoid administration (93-96, 113), alloxan diabetes and insulin therapy (41, 113, 117), growth hormone treatment (118), and acute and prolonged fasting (90, 98, 118, 121). 

Rivkees SA, Danon M, Herrin J. Prednisone dose limitation of growth hormone treatment of steroid-induced growth failure. J Pediatr 1994 125(2) 322-5. 

A 9-year-old girl with trisomy 21 and Prader-Willi syndrome started growth hormone treatment 0.14 mg/ kg/week. She had previously received growth hormone 0.28 mg/kg/week for 12 months at the age of 7 years, but therapy had been stopped at the family s request. Six months later she developed a respiratory infection and died. 

Crepaz R, Pitscheider W, Radetti G, Paganini C, Gentili L, Morini G, Braito E, Mengarda G. Cardiovascular effects of high-dose growth hormone treatment in growth hormone-deficient children. Pediatr Cardiol 1995 16(5) 223-7. 

Bala P, McKiernan J, Gardiner C, O Connor G, Murray A. Turner s syndrome and benign intracranial hypertension with or without growth hormone treatment. J Ped Endocrinol Metab 2004 17 1243 1. 

Lindgren AC. Side effects of growth hormone treatment in Prader-Willi syndrome. Endocrinologist 2000 10(Suppl l) S63-4. 

Picca S, Cappa M, Rizzoni G. Hyperparathyroidism during growth hormone treatment a role for puberty Pediatr Nephrol 2000 14(l) 56-8. 

Sas T, Mulder P, Aanstoot HJ, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A. Carbohydrate metabolism during long-term growth hormone treatment in children with short stature born small for gestational age. Clin Endocrinol (Oxf) 2001 54(2) 243-51. 

Wuhl E, Haffner D, Offner G, Broyer M, van t Hoff W, Mehls OEuropean Study Group on Growth Hormone Treatment in Children with Nephropathic Cystinosis. Long-term treatment with growth hormone in short children with nephropathic cystinosis. J Pediatr 2001 138(6) 880-7. 

Czernichow P, Albertsson-Wikland K, Tuvemo T, 56. Gunnarsson R. Growth hormone treatment and diabetes survey of the Kabi Pharmacia International Growth Study. 

Haffner D, Nissel R, Wuhl E, Schaefer F, Bettendorf M, Tonshoff B, Mehls O. Metabolic effects of long-term growth hormone treatment in prepubertal children with chronic renal failure and after kidney transplantation. 

The German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Pediatr Res 58. 1998 43(2) 209-15. 

Glucose tolerance and insulin secretion in children before and during recombinant growth hormone treatment. Horm... 

Olgaard K, Meeuwisse GW, Rix M, Pedersen FB. 61. Recombinant human growth hormone treatment, using two dose regimens in children with chronic renal fail- 62. ure—a report on linear growth and adverse effects. J Pediatr Endocrinol Metab 2002 15(5) 577-88. 63. 

Cutfield WS, Wilton P, Bennmarker H, Albertsson-Wikland K, Chatelain P, Ranke MB, Price DA. 65. Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. Lancet 2000 355(9204) 610-3. 

Yigit S, Estrada E, Bucci K, Hyams J, Rosengren S. Diabetic ketoacidosis secondary to growth hormone treatment in a boy with Prader-Willi syndrome and steatohe-patitis. J Ped Endocrinol Metab 2004 17 361 —4. 

Antoniazzi F, Bertoldo F, Mottes M, Valli M, Sirpresi S, Zamboni G, Valentini R, Tato L. Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis. J Pediatr 1996 129(3) 432-9. 

Kodama H, Kubota K, Abe T. Osteogenesis imperfecta are fractures and growth hormone treatment linked J Pediatr 1998 132(3 Pt l) 559-60. 

Sipila I, Kaitila I, Bland J, Veimo D, Muller J, Mohnike K, Neumeyer L, Ritzen M, Hagenas L. Growth hormone treatment in 35 prepubertal children with achondroplasia a five-year dose-response trial. Acta Paediatr... 

Riedl S, Bliimel P, Zwiauer K, Frisch H. Death in two female Prader-Willi syndrome patients during the early phase of growth hormone treatment. Acta Paediatr 2005 94 974-7. 

Nagai T, Obata K, Tonoki H, Temma S, Murakamai N, Katada Y, Yoshino A, Sakazume S, Takahashi E, Sakuta R, Niikawa N. Cause of sudden, unexpected death of Prader-Willi syndrome patients with or without growth hormone treatment. Am J Med Genet A 2005 136(l) 45-8. 

Price DA, Wilton P, Jonsson P, Albertsson-Wikland K, Chatelain P, Cutfield W, Ranke MB. Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996. Horm Res 1998 49(2) 91-7. 

Kemp SF, Kuntze J, Attie KM, Maneatis T, Butler MS, Frane J, Lippe B. Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature. J Clin Endocrinol Metab 2005 90 5247-53. 

Quigley CA, Gill AM, Crowe BJ, Robling K, Chipman JJ, Rose SR, Ross JL, Cassorla FG, Wolka AM, Wit JM, Rekers-Mombarg LTM, Cutler GB. Safety of growth hormone treatment in pediatric patients with idiopathic short stature. J Clin Endocrinol Metab 2005 90 5188-96. 

Takala J, Ruokonen E, Webster NR, Nielsen MS, Zandstra DF, Vundelinckx G, Hinds CJ. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999 341(ll) 785-92. 

Saaf, M., Hilding, A., Thoren, M., Troell, S., and Hall, K., Growth hormone treatment of osteoporotic postmenopausal women—A one-year placebo-controlled study. Eur. J. Endocrinol. 140, 390-399 (1999). 

King, S. Bareille, P. Stanhope, R. Re growth hormone treatment without a needle [letter]. J. Pediatr. Endocrinol. Metab. 1998,11 (1), 87. 

---